Critical considerations on the utility of FDG-PET/CT for posttreatment restaging of the bone marrow in diffuse large B-cell lymphoma
Am J Hematol
.
2014 Sep;89(9):935-6.
doi: 10.1002/ajh.23779.
Epub 2014 Jun 23.
Authors
Amie E Jackson
1
,
Thomas E Witzig
Affiliation
1
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
PMID:
24888344
DOI:
10.1002/ajh.23779
No abstract available
Publication types
Letter
Comment
MeSH terms
Cytarabine / pharmacology*
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute / surgery*
Salvage Therapy*
Substances
Cytarabine